Pregled bibliografske jedinice broj: 130583
Efficacy and tolerability of standard doses of ranitidine, omeprasole and pantoprasole in patients with gastro-oesophageal reflux disease (GORD).
Efficacy and tolerability of standard doses of ranitidine, omeprasole and pantoprasole in patients with gastro-oesophageal reflux disease (GORD)., 2002. (ostalo).
CROSBI ID: 130583 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Efficacy and tolerability of standard doses of ranitidine, omeprasole and pantoprasole in patients with gastro-oesophageal reflux disease (GORD).
Autori
Pulanić.Roland: Premužić.Marina:Brkić. Tomislav:Opačić.Milorad:Zorić.Vladimir:Curiš.N
Izvornik
World Congresses of Gastroenterology, Bangkok, Thayland,
Vrsta, podvrsta
Ostale vrste radova, ostalo
Godina
2002
Ključne riječi
GORD; proton pump inhibitors
Sažetak
GERD is a common condition affecting 7% of the population on a daily basis.One of the primary aims of therapy for GORD is to reduce the acidity of refluxed material to which the oesophageal mucosa is exposed. Conclusions: 1.Pharmacologically, acid suppressing therapy with standard doses of PPI has markedly improved the outcome of GORD, 2. Within PPI classes, pantoprasole has much better results (fewer GORD symptoms, fewer side-effects, better E and HA improvement), 3.Pantoprasole is highly effective and well tolerated in the treatment of GORD.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
